Despite considerable investment and innovation, chemotherapy drugs have had little effect on survival in adults with metastatic cancer.
In this podcast, Navjoyt Ladher, clinical editor for The BMJ, talks to Peter Wise, former consultant physician and senior lecturer Imperial College School of Medicine, and author of a recent analysis on TheBMJ.com
Read the full analysis:
http://www.bmj.com/content/355/bmj.i5792
